Castle Pharma Holdings Ltd iXBRL

Castle Pharma Holdings Ltd

Date of Incorporation

9 January 2024

Unaudited Financial Statements

for the financial period ended 31 January 2025

Castle Pharma Holdings Ltd

Company Registration Number: NI707861

STATEMENT OF FINANCIAL POSITION

as at 31 January 2025

		Jan 25
		£
	ASSETS
	Fixed Assets	1,280,991
	Current assets	449,881
		─────────
		1,730,872
		═════════
	CAPITAL, RESERVES AND LIABILITIES
	Capital and Reserves	691,979
	Creditors: amounts falling due within one year	168,049
	Accruals and deferred income	750
	Creditors: amounts falling due after more than one year	870,094
		─────────
		1,730,872
		═════════

	Notes to the Financial statements

General Information

Castle Pharma Holdings Ltd is a company limited by shares incorporated and registered in Northern Ireland. The registered number of the company is NI707861. The registered office of the company is 16 Mount Charles, Belfast, BT7 1NZ, United Kingdom which is also the principal place of business of the company. The financial statements have been presented in Pound (£) which is also the functional currency of the company.

Employees

The average monthly number of employees, including director, during the financial period was 1, (Jan 24 - 0).

Jan 25

Number

Director

═════════

Post-Balance Sheet Events

There have been no significant events affecting the company since the financial period-end.

For the financial period ended 31 January 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006.

The director confirms that the members have not required the company to obtain an audit of its financial statements for the financial period in question in accordance with section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for ensuring that the company keeps accounting records which comply with section 386 and for preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of the financial period and of its profit and loss for the financial period in accordance with the requirements of sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

These financial statements have been prepared in accordance with the provisions available to micro-entities in Part 15 of the Companies Act 2006 and delivered in accordance with the provisions applicable to companies subject to the small companies' regime.

The company has taken advantage of the exemption under section 444 not to file the Income Statement.

Approved by the Director on 10 September 2025 and signed by:

________________________________

Lee Dearn

Director